Sandoz Omnitrope Gains First “Similar Biological” Positive Opinion In the EU
This article was originally published in The Pink Sheet Daily
Executive Summary
Recombinant-DNA growth hormone would be approved through new pathway by demonstrating comparable safety and efficacy to Genotropin.